In a new crossover study, investigators found once-daily prednisolone was as effective as multi-dose hydrocortisone, ...

BCMA-directed cell therapy can offer a targeted mechanism of action that modulates myasthenia gravis pathology, Vu noted.

In the WAYFINDER trial, tezepelumab reduced oral corticosteroid use in patients with severe asthma, with well-controlled ...

The new guidelines include three strong recommendations: Universal treatment with hydroxychloroquine (absent ...

The drug, dubbed ianalumab, both depletes B cells and deactivates those remaining, Thomas Grader-Beck, MD, of Johns Hopkins ...

During her lecture, "Paws in motion: Addressing mobility loss in senior dogs," at the 2025 Global Hill’s Symposium, Natasha Olby, Vet MB, PhD, MRCVS, DACVIM (Neurology), shares how veterinary teams ...

Patients who depended on oral corticosteroids to care for their severe asthma experienced improvements in asthma control ...

Q2 2026 Earnings Call Transcript November 10, 2025 Roivant Sciences Ltd. beats earnings expectations. Reported EPS is ...

Q2 2026 Earnings Call Transcript November 10, 2025 Immunovant, Inc. misses on earnings expectations. Reported EPS is ...

Long-term OGC use was associated with greater economic burden and higher complication rates among patients with DM or PM compared with short-term users.

The current recommended urine protein to creatinine ratio is arbitrary, and a lower bar would capture more lupus nephritis onset, researchers say. They make a case for changing the guidelines.

Swiss specialty drugmaker Santhera Pharmaceuticals saw its shares rise 5.8% to 10.90 francs today, after it reported positive ...